Stem Cell Therapy for Multiple Sclerosis

Stem cell therapy for multiple sclerosis has already been medically reviewed.

Typically occurs in adults aged 20 to 40 years

What is multiple sclerosis?

Multiple sclerosis (MS) is a chronic and typically progressive autoimmune disease that affects the central nervous system (CNS), which includes the brain, spinal cord, and optic nerves. In MS, the immune system mistakenly attacks the protective covering of nerve fibers called myelin, causing inflammation and damage to the myelin sheath and sometimes to the underlying nerves.
This damage disrupts the normal flow of electrical impulses along the nerves, leading to a variety of symptoms that can vary widely among individuals. Common symptoms of MS include fatigue, muscle weakness, coordination and balance problems, numbness or tingling, vision issues, cognitive changes, and difficulties with bladder or bowel function.

The main types of MS

Multiple Sclerosis (MS) is classified into several types, each reflecting the disease’s severity, progression, and pattern of symptoms. Understanding these types helps in diagnosing, managing, and treating the condition effectively. The main types of MS include:

Relapsing-Remitting MS (RRMS)

This is the most common form of MS, characterized by clearly defined attacks of new or increasing neurologic symptoms (relapses) followed by periods of partial or complete recovery (remissions). During remissions, symptoms may improve partially or completely, and there is no apparent progression of the disease.

Primary-Progressive MS (PPMS)

This type is characterized by a steady worsening of neurologic function from the onset of symptoms, without early relapses or remissions. There may be occasional plateaus or minor improvements, but overall, the progression is continuous.

Secondary-Progressive MS (SPMS)

SPMS follows an initial relapsing-remitting course. Over time, the disease begins to progress more steadily, with or without relapses. This means that there is a gradual worsening of neurologic function over time.

Progressive-Relapsing MS (PRMS)

This is a rare form of MS, characterized by a steadily progressing disease from the onset, with clear relapses. In PRMS, people experience steadily worsening neurologic function from the beginning, with occasional acute relapses but no remissions.

Ask our team Doctor
about your health.

Last Name

First Name

E-mail*

Residence Nationality*

Phone Number*

Age

What Program Do You Need?

Your Message*

Consent for Collection and Use of Personal Information

Beneficial actions of stem cells in neurological diseases

Stem cell role in Multiple Sclerosis treatment

The exact cause of multiple sclerosis is not known, but it is believed to be a combination of genetic predisposition, environmental factors, and specific viral infections.

Basically, various drugs are used because there is a problem with the plasma and antibodies that play an immune function in the blood. Although these medications are aimed at managing symptoms and slowing their progression, their use can cause serious side effects and may stop working for some patients.

However Recently, stem cell therapies, including HSCT, and the use of mesenchymal stem cells obtained from sources such as the umbilical cord have emerged as potential treatments for multiple sclerosis (MS).
For patients with Progressive-Relapsing MS (RRMS), hematopoietic stem cell transplant treatment is performed in addition to powerful chemotherapy. This is a treatment aimed at resetting one’s immune system and making it healthy.
Moreover, our hospital’s stem cell treatment uses umbilical cord-derived mesenchymal stem cells to help with rehabilitation, such as recovery from decline in physical function caused by MS. The use of umbilical cord-derived mesenchymal stem cells is based on their potential to modulate immune system responses and promote tissue repair. Mesenchymal stem cells have been shown to have immunomodulatory and anti-inflammatory effects, which may help treat autoimmune diseases such as MS by promoting repair of myelin and neural tissue and potentially halting disease progression.

Because the experience of multiple sclerosis varies greatly from person to person, treatment plans must be tailored to the patient’s specific situation and needs.